A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)

NCT ID
NCT07843459
Registry status
Not yet recruiting
Study type
Interventional
Phase
Phase 1
Sponsor
Eli Lilly and Company
Conditions
Alzheimer Disease, Amyloid, Healthy Volunteers, Plaque, Amyloid, Plasma

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Official title: A Placebo-Controlled, Single- and Multiple-Ascending Dose, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease

Enrollment: 111 participants (Estimated).

What is being studied

  • Intervention: 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
  • Other: Florbetaben F 18
  • Intervention: florbetapir
  • Other: Florbetapir F18
  • Drug: LY4560736
  • Drug: Placebo

Who may be eligible

Ages
18 Years to 85 Years
Sex
All
Healthy volunteers accepted
Yes

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Participants must meet eligibility criteria in the A1D-MC-ATMP screening protocol before entry into the treatment study. * To qualify as a participant of first-generation Japanese origin, the participant, the participant's biological parents, and all the participant's biological grandparents must be of exclusive Japanese descent and born in Japan. * To qualify as Chinese for this study, all four of the participant's biological grandparents must be of exclusive Chinese descent and born in China. Exclusion Criteria: * Have a condition that predisposes the participant to an infection. * Have a current or recent acute, active infection. * Have active tuberculosis (TB), have or have had latent TB. * Are receiving therapeutic antibodies or expected to initiate treatment with therapeutic antibodies during the study.

Study locations

18 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: China, Japan, United States

  • California, United States: 3
  • Florida, United States: 8
  • Georgia, United States: 1
  • Michigan, United States: 1

Sample of listed locations

  • Xuanwu Hospital Capital Medical University — Beijing, 100053, China — Site recruitment status not specified in the registry data
  • Huashan Hospital, Fudan University — Minhang District, 201107, China — Site recruitment status not specified in the registry data
  • Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine — Shanghai, 200127, China — Site recruitment status not specified in the registry data
  • The University of Tokyo Hospital — Bunkyō City, 113-8655, Japan — Site recruitment status not specified in the registry data
  • National Center for Geriatrics and Gerontology — Ōbu, 4748511, Japan — Site recruitment status not specified in the registry data
  • CenExel ACT — Anaheim, California, 92801, United States — Site recruitment status not specified in the registry data
  • Irvine Clinical Research — Irvine, California, 92614, United States — Site recruitment status not specified in the registry data
  • Collaborative Neuroscience Network - CNS — Los Alamitos, California, 90720, United States — Site recruitment status not specified in the registry data
  • Fortrea Clinical Research Unit — Daytona Beach, Florida, 32117, United States — Site recruitment status not specified in the registry data
  • K2 Medical Research - The Villages — Lady Lake, Florida, 32159, United States — Site recruitment status not specified in the registry data
  • K2 Medical Research — Maitland, Florida, 32751, United States — Site recruitment status not specified in the registry data
  • Charter Research — Orlando, Florida, 32803, United States — Site recruitment status not specified in the registry data
  • Progressive Medical Research — Port Orange, Florida, 32127, United States — Site recruitment status not specified in the registry data
  • Alzheimer's Research and Treatment Center — Stuart, Florida, 34996, United States — Site recruitment status not specified in the registry data
  • K2 Medical Research - Tampa — Tampa, Florida, 33634, United States — Site recruitment status not specified in the registry data
  • Charter Research — The Villages, Florida, 32162-2698, United States — Site recruitment status not specified in the registry data
  • Accel Research Sites - NeuroStudies Clinical Research Unit — Decatur, Georgia, 30030, United States — Site recruitment status not specified in the registry data
  • QUEST Research Institute — Farmington Hills, Michigan, 48334, United States — Site recruitment status not specified in the registry data

Study details

Start date
October 1, 2026
Primary completion date
July 1, 2028
Completion date
July 1, 2028
First posted
September 28, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07843459
Registry last updated
October 8, 2026
QualifiedStudies registry data refreshed
October 12, 2026
QualifiedStudies record fetched
October 12, 2026

View NCT07843459 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Clinical trial FAQ